Go back

Qdossier Qsauri
"C"

controlled correspondance
Guideline or reference source
FDAGDUFA Generic Drug User Fee Amendments 2012
Definition
FDA’S Office of Generic Drugs provides assistance to pharmaceutical firms and related industry regarding a variety of questions posed as "controlled documents." See http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm120610.htm2. Controlled correspondence does not include citizen petitions, petitions for reconsideration or requests for stay.  

Send comments to info@qdossier.com Please read disclaimer before using Qsauri.